Intravitreal Bevacizumab Improved Vision In Most Patients With Myopic CNV

Wednesday, March 7, 2007

Comments

OSN SuperSite

Intravitreal bevacizumab safely improved vision in most patients with choroidal neovascularization secondary to pathological myopia, according to two small studies in the February issue of the British Journal of Ophthalmology.

Full Story

Which of the following is NOT a risk factor for suprachoroidal hemorrhage?
1. Previous lasik surgery
2. Preoperative high intraocular pressure
3. Aphakia
4. Previous vitreous surgery
Check The Answer

PanoCam™ LT Wide-field Digital Imaging System
The PanoCam LT represents the first ... view product
Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Intravitreal Bevacizumab Improved Vision In Most Patients With Myopic CNV

Comments

Quick Quiz

Which of the following is NOT a risk factor for suprachoroidal hemorrhage?

AdGlare RMR Ad

Featured Products

PanoCam™ LT Wide-field Digital Imaging System

Smartphone-Based Retinal Screening System

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us